达安基因

- 002030

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
达安基因(002030) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入19,830.77118,089.7184,233.6253,621.8434,103.81
营业收入19,830.77118,089.7184,233.6253,621.8434,103.81
二、营业总成本20,795.15113,344.0882,299.5355,421.0733,165.59
营业成本8,758.1258,492.9138,071.6825,252.8915,088.95
营业税金及附加122.32978.17460.03285.32126.48
销售费用2,541.9017,283.3313,565.3910,247.085,316.95
管理费用5,341.4413,831.3414,063.309,785.356,161.50
财务费用-1,608.76-7,474.89-6,133.33-5,340.38-1,169.06
研发费用5,640.1230,233.2222,272.4515,190.817,640.77
资产减值损失----------
公允价值变动收益-36,557.2943,569.0640,329.1647,996.022,357.42
投资收益-2,209.61-2,624.67-33.502,009.00-1,310.68
其中:对联营企业和合营企业的投资收益-2,586.42-4,610.08-1,359.72690.06-1,593.81
汇兑收益----------
三、营业利润-43,330.6912,162.1943,153.3948,910.025,052.30
加:营业外收入12.65188.96153.49149.395.72
减:营业外支出88.77997.55348.60328.2165.51
其中:非流动资产处置损失----------
四、利润总额-43,406.8111,353.5942,958.2948,731.204,992.52
减:所得税费用-7,292.724,180.448,347.988,891.931,214.73
五、净利润-36,114.097,173.1634,610.3139,839.273,777.79
归属于母公司所有者的净利润-36,329.0610,465.9635,259.4440,275.543,656.14
少数股东损益214.98-3,292.80-649.13-436.27121.66
六、每股收益
基本每股收益(元/股)-0.25890.07460.25120.29000.0261
稀释每股收益(元/股)-0.25890.07460.25120.29000.0261
七、其他综合收益22.05-86.7142.3340.09-36.96
八、综合收益总额-36,092.047,086.4534,652.6439,879.373,740.83
归属于母公司所有者的综合收益总额-36,306.7010,359.2435,284.2940,294.793,630.29
归属于少数股东的综合收益总额214.67-3,272.79-631.65-415.43110.54
下载全部历史数据到excel中 返回页顶